Scotland · NHS Scotland MSAN
Tolterodine 2mg and 4mg modified-release capsules
MSAN(2025)25 · Level 2 · issued 27 May 2025
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Tolterodine 2mg and 4mg modified-release (MR) capsules are in limited supply until mid-August | Limited supply | mid-August |
| 2. Tolterodine 1mg and 2mg immediate release (IR) tablets remain available and can support | Available | — |
| 3. Alternative once-daily antimuscarinics also remain available and can support increased | Available | — |
| you need to register with the SPS website. Registration for access to the website is available to | Available | — |
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
scot:msan:2025:25
- Recorded
- 13 Aug 2026 22:03 UTC
- Capture route
- Captured first-hand by ShortageSignal's scheduled check
- Read from
- NHS Scotland Medicine Supply Alert Notice (PDF)
- Captured at
- 13 Aug 2026 22:03 UTC
- Content hash
9317dc467fb120b97f20bd0d182077f0744f5b5fc84f77cd93064a355466770esha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://www.publications.scot.nhs.uk/files/msan-2025-25.pdf ↗
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.